New Evidence on the Effect of The Individual Mandate On Seniors

  • by: |
  • 03/27/2012
Under-treatment is a result of government health systems undervaluing us as we get older and are faced with life threatening illnesses.   And it's a product of 1.  using comparative effectiveness research to guide reimbursement and treatment decisions and
2.   the fact that CER standards and information is not only controlled by government but used in 'academic detailing' of doctors while private companies are banned to discuss new treatments..

UK elderly "being denied cancer treatment"


Under-treatment is one of a number of factors contributing to around 14,000 avoidable cancer deaths in patients aged over 75 in the UK every year, according to a new report.

Cancer mortality rates are getting significantly better for the under-75s, but they are improving at a much slower rate in those aged 74-84 and actually getting worse for people aged 85 and over, says the study, from Macmillan Cancer Support.

PREDICT charter underlines trial bias against older people
The number of people living with a cancer diagnosis is set to rise from two to four million in the next 20 years, and, with half of all new cancer cases in the UK diagnosed in people aged 70 or over, this is an issue which must be addressed as a matter of urgency, says Macmillan.

According to the report, some of the reasons why older patients are less likely to receive treatment than those who are younger include:
- recommendations on treatment are too often being made on the basis of age, regardless of how fit patients may be;
- assessments do not adequately measure an older person's fitness for treatment, and co-existing health problems are often not identified or effectively managed;
- many patients do not take up treatment because they have inadequate practical support to help them at home, with transport, or with care for dependent spouses and other family;
- older people are not represented on enough clinical trials, reducing the amount of evidence available to clinicians on the benefits and risks of cancer treatment and its impact on quality of life: and
- oncologists and cancer surgeons need more support to manage issues specific to older people such as falls, incontinence and multi-drug use. In a survey of 98 oncology trainees, 60% reported that they have never received any training in the particular needs of older people with cancer, despite them making up half of numbers getting cancer each year, the study reports.
"To deny older patients treatment that could cure them based on ill-founded assumptions is an unacceptable act of discrimination," said Ciaran Devane, chief executive of Macmillan Cancer Support.

"We have a moral duty to treat people as individuals and give them the best chance of beating cancer, regardless of their age," he stressed.
"Efforts are begin made to increase early diagnosis and promote healthier lifestyles, but much more needs to be done to tackle under-treatment. The NHS and social care providers must wake up to the specific issues older people face and ensure treatment decisions are based on their overall health, not just their date of birth," said Mr Devane, adding: "writing people off as too old for treatment is utterly shameful."

Added Professor Riccardo Audisio, consultant surgical oncologist at St Helen's Hospital: " it is despicable to neglect, not to offer, not to even go near to the best treatment option only on the simple basis of the patient's age. This has been a horrible mistake that, particularly in the UK, we have suffered from."
Macmillan has, in partnership with Age UK and the Department of Health, set up five pilots to test new models of older people's care. They will report in December this year.

- Meantime, the National Cancer Intelligence Network (NCIN) reported yesterday that almost 10% of bowel cancer patients die within a month of being diagnosed, and of these 56% are over 80% years old, while 60% have been diagnosed following an emergency admission to hospital

Center for Medicine in the Public Interest is a nonprofit, non-partisan organization promoting innovative solutions that advance medical progress, reduce health disparities, extend life and make health care more affordable, preventive and patient-centered. CMPI also provides the public, policymakers and the media a reliable source of independent scientific analysis on issues ranging from personalized medicine, food and drug safety, health care reform and comparative effectiveness.

Blog Roll

Alliance for Patient Access Alternative Health Practice
Better Health
Biotech Blog
CA Medicine man
Cafe Pharma
Campaign for Modern Medicines
Carlat Psychiatry Blog
Clinical Psychology and Psychiatry: A Closer Look
Conservative's Forum
Club For Growth
Diabetes Mine
Disruptive Women
Doctors For Patient Care
Dr. Gov
Drug Channels
DTC Perspectives
Envisioning 2.0
FDA Law Blog
Fierce Pharma
Fresh Air Fund
Furious Seasons
Gel Health News
Hands Off My Health
Health Business Blog
Health Care BS
Health Care for All
Healthy Skepticism
Hooked: Ethics, Medicine, and Pharma
Hugh Hewitt
In the Pipeline
In Vivo
Internet Drug News
Jaz'd Healthcare
Jaz'd Pharmaceutical Industry
Jim Edwards' NRx
Kaus Files
Laffer Health Care Report
Little Green Footballs
Med Buzz
Media Research Center
More than Medicine
National Review
Neuroethics & Law
Nurses For Reform
Nurses For Reform Blog
Opinion Journal
Orange Book
Peter Rost
Pharm Aid
Pharma Blog Review
Pharma Blogsphere
Pharma Marketing Blog
Pharmacology Corner
Pharmaceutical Business Review
Piper Report
Prescription for a Cure
Public Plan Facts
Real Clear Politics
Shark Report
Shearlings Got Plowed
Taking Back America
Terra Sigillata
The Cycle
The Catalyst
The Lonely Conservative
Town Hall
Washington Monthly
World of DTC Marketing
WSJ Health Blog